Lemtrada
- Licence status
- Active substances
- Alemtuzumab
- Dosage Form
- Concentrate for solution for infusion
- Licence number
- EU/1/13/869/001
- Licence holder
- Sanofi Belgium
Product documents
Licence information
- ATC code
- L04AA Selective immunosuppressants, L04AA34 Selective immunosuppressants
- Route of supply
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal products on “restricted” medical prescription, reserved for use in certain specialised areas (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
Educational materials for healthcare professionals
Educational materials for patients
Stay updated: document advice
The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie